Prague Med. Rep. 2026, 127, 119-131
https://doi.org/10.14712/23362936.2026.18
Chronotherapeutic Considerations in Immunotherapy: A Case of Durable Response in Metastatic Non-small Cell Lung Cancer
Ivan Bivolarski
Oncology Centre in Burgas, Burgas, Bulgaria
Received July 9, 2025
Accepted June 2, 2026
References
1. , H. M., Hasan, A. H., Suleiman, M., Ahmad Zahidi, M. A., Noamaan, M. A., Alexyuk, P., Alexyuk, M., Bogoyavlenskiy, A., Jamalis, J. (2024) Benzyloxychalcone hybrids as prospective acetylcholinesterase inhibitors against Alzheimer’s disease: Rational design, synthesis, in silico ADMET prediction, QSAR, molecular docking, DFT, and molecular dynamic simulation studies. ACS Omega 9(30), 32901–32919.
2. , A., Verdugo-Sivianes, E. M., Carnero, A., Blanco, J. (2022) Chronotherapy: Circadian rhythms and their influence in cancer therapy. Cancers 14(20), 5071.
<https://doi.org/10.3390/cancers14205071>
3. , D. D., Bashoura, L., Sheshadri, A., Manzullo, E., Faiz, S. A. (2023) The impact of immunotherapy on sleep and circadian rhythms in patients with cancer. Front. Oncol. 13, 1295267.
<https://doi.org/10.3389/fonc.2023.1295267>
4. , M., Baty, F., Rassouli, F., Kowatsch, T., Joerger, M., Früh, M., Brutsche, M. H. (2023) Non-pharmaceutical interventions to optimize cancer immunotherapy. Oncoimmunology 12(1), 2255459.
<https://doi.org/10.1080/2162402X.2023.2255459>
5. , A., Vitullo, P., Di Gioia, S., Castellani, S., Conese, M. (2024) A new frontier in cystic fibrosis pathophysiology: How and when clock genes can affect the inflammatory/immune response in a genetic disease model. Curr. Issues Mol. Biol. 46(9), 10396–10410.
<https://doi.org/10.3390/cimb46090618>
6. , S., Assaad, S., Delrieu, L., Favier, B., Dumas, E., Hamy, A., Latouche, A., Crochet, H., Blay, J., Mullaert, J., Ballesta, A., Heudel, P. (2024) Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An in-depth chronotherapeutic study. Eur. J. Cancer 199, 113571.
<https://doi.org/10.1016/j.ejca.2024.113571>
7. , Y., Yao, J., Fang, Q., Chen, B., Zang, G. (2022) A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Aging 14(23), 9617–9631.
8. , L., Ilderbayev, O., Taldykbayev, Z., Ilderbayeva, G., Argynbekova, A. (2018) Phytocorrection of immunological and biochemical changes in the combined impact of coal dust and high dose of radiation. Georgian Med. News Issue, 141–150. (in Russian)
9. , J., Chen, P., Qi, C. (2024) Circadian rhythm regulation in the immune system. Immunology 171(4), 525–533.
<https://doi.org/10.1111/imm.13747>
10. , Z., Holme, P. (2020) Coupling the circadian rhythms of population movement and the immune system in infectious disease modeling. PLoS One 15(6), e0234619.
<https://doi.org/10.1371/journal.pone.0234619>
11. , M. B., Berezenko, V. S. (2023) Possibilities of shear wave elastography in the diagnosis of liver fibrosis and monitoring of autoimmune liver diseases in children. Modern Pediatr. Ukraine 8, 34–41.
<https://doi.org/10.15574/SP.2023.136.34>
12. , M., Berezenko, V., Zabara, D., Bezpala, A., Donskoi, B. (2024) Monocyte subpopulations in children with autoimmune liver disease. Pathol. Res. Pract. 263, 155622.
<https://doi.org/10.1016/j.prp.2024.155622>
13. , R. M., Billo, A., Clister, T., Doan, K. L., Berry, E. G., Tibbitts, D. C., Kulkarni, R. P. (2025) Personalization of cancer treatment: Exploring the role of chronotherapy in immune checkpoint inhibitor efficacy. Cancers 17(5), 732.
<https://doi.org/10.3390/cancers17050732>
14. , N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., Mograbi, B. (2023) Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: From dream to reality. Trends Mol. Med. 29(11), 897–911.
<https://doi.org/10.1016/j.molmed.2023.08.004>
15. , J. A., Anafi, R., Brown, M. K., Cermakian, N., Depner, C., Desplats, P., Gelman, A. E., Haack, M., Jelic, S., Kim, B. S., Laposky, A. D., Lee, Y. C., Mongodin, E., Prather, A. A., Prendergast, B., Reardon, C., Shaw, A. C., Sengupta, S., Szentirmai, É., Thakkar, M., Walker, W. E., Solt, L. A. (2020) Perfect timing: Circadian rhythms, sleep, and immunity – An NIH workshop summary. JCI Insight 5(1), e131487.
<https://doi.org/10.1172/jci.insight.131487>
16. , S., Holtkamp, S., Scheiermann, C. (2020) Molecular interactions between components of the circadian clock and the immune system. J. Mol. Biol. 432(12), 3700–3713.
<https://doi.org/10.1016/j.jmb.2019.12.044>
17. , D. B., Nebhan, C. A., Moslehi, J. J., Balko, J. M. (2022) Immune-checkpoint inhibitors: Long-term implications of toxicity. Nat. Rev. Clin. Oncol. 19(4), 254–267.
<https://doi.org/10.1038/s41571-022-00600-w>
18. , G., Roji, A., Seferi, A., Cakani, B., Bushati, T., Roci, E., Petrela, M. (2014) Spinal dissemination of intracranial glioblastoma in bevacizumab era: A potential bevacizumab-induced mechanism. Acta Inform. Med. 22(2), 142–144.
<https://doi.org/10.5455/aim.2014.22.142-144>
19. , A., Innominato, P. F., Wreglesworth, N. I., Duchemann, B., Adam, R., Lévi, F. A. (2024) Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy? Br. J. Cancer 131(5), 783–796.
<https://doi.org/10.1038/s41416-024-02704-9>
20. , M., Mazuch, J., Abraham, U., Eom, G. D., Herzog, E. D., Volk, H., Kramer, A., Maier, B. (2009) A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. U. S. A. 106(50), 21407–21412.
<https://doi.org/10.1073/pnas.0906361106>
21. , A. M., Moroz, L. V., Bevz, T. I., Bulavenko, V. I., Antypkin, Y. G., Berezenko, V. S., Dyba, M. B., Pampukha, V. M., Gorodna, O. V., Livshits, L. A. (2019) Investigation of rs11536889 + 3725G/C polymorphism of the TLR4 gene in patients with autoimmune and chronic viral hepatitis C. Cytol. Genet. 53(4), 300–306.
<https://doi.org/10.3103/S0095452719040078>
22. , N., Cermakian, N. (2015) Circadian clocks in the immune system. J. Biol. Rhythms 30(4), 277–290.
<https://doi.org/10.1177/0748730415577723>
23. , K., Kolodziej, W., Pawus, D., Bielecki, M., Latka, D. (2024) Performance of successful ambulatory cervical spine surgery: Safety, efficacy, and early experiences of first 100 cases in Poland. Br. J. Neurosurg. 39(6), 807–812.
<https://doi.org/10.1080/02688697.2024.2378825>
24. , K., Kołodziej, W., Pawuś, D., Waligóra, M., Trompeta, J., Klepinowski, T., Lasowy, P., Tanaka, M., Łabuz-Roszak, B., Łątka, D. (2024) Extremely rare complications in uniportal spinal endoscopy: A systematic review with unique case analyses. J. Clin. Med. 13(6), 1765.
<https://doi.org/10.3390/jcm13061765>
25. , F. A., Okyar, A., Hadadi, E., Innominato, P. F., Ballesta, A. (2023) Circadian regulation of drug responses: Toward sex-specific and personalized chronotherapy. Annu. Rev. Pharmacol. Toxicol. 64(1), 89–114.
<https://doi.org/10.1146/annurev-pharmtox-051920-095416>
26. , X., Rothämel, P., Nussbaum, C., Sperandio, M., Scheiermann, C. (2025) Development of a circadian immune system. Trends Immunol. 46(9), 614–623.
<https://doi.org/10.1016/j.it.2025.06.004>
27. , I. M., Tamm, T. I., Kramarenko, K. O., Ryabushchenko, D. D., Sytnik, D. A., Nepomniashchyi, V. V., Bardiuk, O. Y. (2023) Endoscopic retrograde cholangiopancreatography and endoscopic decompression in the malignant obstruction of the extrahepatic biliary tracts – A retrospective analysis. Ukr. J. Radiol. Oncol. 31(1), 28–37. (in Ukrainian)
28. , Y., Chemerys, O., Zimenkovsky, B., Drapak, I., Matiychuk, V. (2025) Synthesis and anticancer activity of aminothiazole-terminal phenoxycompounds hybrids and their analogs: A short review. Chem. Chem. Technol. 19(1), 61–78.
<https://doi.org/10.23939/chcht19.01.061>
29. , G., Vinciguerra, M., Carbone, A., Relógio, A. (2020) The circadian clock, the immune system, and viral infections: The intricate relationship between biological time and host-virus interaction. Pathogens 9(2), 83.
<https://doi.org/10.3390/pathogens9020083>
30. , P., Domenicucci, M., Paolini, S., Mancarella, C., Tola, S., D’Elia, A., Marotta, N., Seferi, A., Esposito, V. (2016) Emergency decompressive craniectomy after removal of convexity meningiomas. Surg. Neurol. Int. 7(1), 193098.
<https://doi.org/10.4103/2152-7806.193098>
31. , H., Ostendorf, E., Ganninger, A., Adler, A. J., Hazan, G., Haspel, J. A. (2024) Circadian immunity from bench to bedside: A practical guide. J. Clin. Invest. 134(3), e175706.
<https://doi.org/10.1172/JCI175706>
32. , N. S., Kushaliyev, K. Z., Shalmenov, M., Gusmanov, M. G., Sadenov, M. M. (2015) Haematological, biochemical and immunomorphologic changes in dogs with melanoma and melanocytoma. Biosci. Biotechnol. Res. Asia 12(1), 321–326.
<https://doi.org/10.13005/bbra/1668>
33. , N. S., Kushaliyev, K. Z., Grabarević, Z. (2016) Early symptoms of malignancy in the appearance of melanoma in dogs. Biol. Med. (Aligarh) 8(1), BM-163-16.
34. , S., Hussein, A., Kesselman, M. M. (2025) The importance of timing in immunotherapy: A systematic review. Cureus 17(4), e82994.
35. , B. E., Andersen, C., Yuan, Y., Hong, D. S., Naing, A., Karp, D. D., Yap, T. A., Ahnert, J. R., Campbell, E., Tsimberidou, A. M., Dumbrava, E. E., Fu, S., Piha-Paul, S. A., Pant, S., Blumenschein, G. R., Altan, M., Tawbi, H. A., Tannir, N. M., Meric-Bernstam, F., Subbiah, V. (2022) Effect of immunotherapy and time-of-day infusion chronomodulation on survival in advanced cancers. J. Clin. Oncol. 40(16_Suppl.), 1588.
<https://doi.org/10.1200/JCO.2022.40.16_suppl.1588>
36. , M., Issilbayeva, A., Bersimbaev, R., Ilderbayev, O., Vinogradova, E., Jarmukhanov, Z., Nurgozhina, A., Sergazy, S., Kozhabergen, N., Akhmetova, Z., Meiramova, A., Chulenbayeva, L., Ibrayeva, A., Mukhanbetzhanov, N., Mukhanbetzhanova, Z., Kozhakhmetov, S., Ainabekova, B., Kushugulova, A. (2024) Gut microbiome-immune interactions and their role in rheumatoid arthritis development. PeerJ 12(7), e17477.
<https://doi.org/10.7717/peerj.17477>
37. , S. M., Verdugo-Sivianes, E. M., Amiama-Roig, A., Blanco, J. R., Carnero, A. (2023) Interactions of circadian clock genes with the hallmarks of cancer. Biochim. Biophys. Acta Rev. Cancer 1878(3), 188900.
<https://doi.org/10.1016/j.bbcan.2023.188900>
38. , J. S., Woo, Y., Draper, A., Jansen, C. S., Carlisle, J. W., Innominato, P. F., Lévi, F. A., Dhabaan, L., Master, V. A., Bilen, M. A., Khan, M. K., Lowe, M. C., Kissick, H., Buchwald, Z. S., Qian, D. C. (2024) Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: A multicenter cohort analysis. J. Immunother. Cancer 12(3), e008011.
<https://doi.org/10.1136/jitc-2023-008011>
39. , D. C., Kleber, T., Brammer, B., Xu, K. M., Switchenko, J. M., Janopaul-Naylor, J. R., Zhong, J., Yushak, M. L., Harvey, R. D., Paulos, C. M., Lawson, D. H., Khan, M. K., Kudchadkar, R. R., Buchwald, Z. S. (2021) Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): A propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 22(12), 1777–1786.
<https://doi.org/10.1016/S1470-2045(21)00546-5>
40. , M., Van Os, M., Van Laake, L. W., Bovenschen, N., Crnko, S. (2024) Integration of circadian rhythms and immunotherapy for enhanced precision in brain cancer treatment. EBioMedicine 109, 105395.
<https://doi.org/10.1016/j.ebiom.2024.105395>
41. , L. A., van Vloten, J. P., AuYeung, A. W. K., Mould, R. C., Yates, J. G. E., McAusland, T. M., Petrik, J. J., Major, P. P., Bridle, B. W., Wootton, S. K. (2024) Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer. Front. Microbiol. 15, 1325558.
<https://doi.org/10.3389/fmicb.2024.1325558>
42. , C., Kunisaki, Y., Frenette, P. S. (2013) Circadian control of the immune system. Nat. Rev. Immunol. 13(3), 190–198.
<https://doi.org/10.1038/nri3386>
43. , A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., Zitvogel, L. (2023) Gut oncomicrobiome signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. Nat. Rev. Clin. Oncol. 20(9), 583–603.
<https://doi.org/10.1038/s41571-023-00785-8>
44. , M., Rudyk, D., Aslanian, S., Chub, S., Besedinskyi, M. (2024) Recurrent variceal bleeding in alcoholic liver cirrhosis (a case report). Gastroenterology 58(3), 222–225.
<https://doi.org/10.22141/2308-2097.58.3.2024.627>
45. , W. H., Bumgarner, J. R., Becker-Krail, D. D., May, L. E., Liu, J. A., Nelson, R. J. (2021) Light at night disrupts biological clocks, calendars, and immune function. Semin. Immunopathol. 44(2), 165–173.
<https://doi.org/10.1007/s00281-021-00899-0>
46. , C., Barnoud, C., Cenerenti, M., Sun, M., Caffa, I., Kizil, B., Bill, R., Liu, Y., Pick, R., Garnier, L., Gkountidi, O. A., Ince, L. M., Holtkamp, S., Fournier, N., Michielin, O., Speiser, D. E., Hugues, S., Nencioni, A., Pittet, M. J., Jandus, C., Scheiermann, C. (2022a) Dendritic cells direct circadian anti-tumour immune responses. Nature 614(7946), 136–143.
<https://doi.org/10.1038/s41586-022-05605-0>
47. , C., Lutes, L. K., Barnoud, C., Scheiermann, C. ( 2022b) The circadian immune system. Sci. Immunol. 7(72), eabm2465.
<https://doi.org/10.1126/sciimmunol.abm2465>
48. , Y., Liu, P., Wei, J., Zhang, X., Guo, J., Lin, Y. (2023) Recent progress in targeted therapy for non-small cell lung cancer. Front. Pharmacol. 14, 1125547.
<https://doi.org/10.3389/fphar.2023.1125547>
49. , C., Kartolo, A., Tong, J., Hopman, W., Baetz, T. (2023) Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma. Immunotherapy 15(11), 819–826.
<https://doi.org/10.2217/imt-2022-0139>
